US equities
|
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SKHY
$142.87
▲+0.00%
SPCX
$147.96
▲+0.00%
TSLA
$368.06
▲+0.00%
AAPL
$342.94
▲+0.00%
CRWV
$61.12
▲+0.00%
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SKHY
$142.87
▲+0.00%
SPCX
$147.96
▲+0.00%
TSLA
$368.06
▲+0.00%
AAPL
$342.94
▲+0.00%
CRWV
$61.12
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about KHTRF
Recent news which mentions KHTRF
Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America
May 24, 2022
Tickers
KHTRF
RIGL
Tags
Penny Stocks
Benzinga
Market News
From
Benzinga